Publications by authors named "Devon Heroux"

Claim this Profile
L
Liposomal delivery of a disulfiram metabolite drives copper-mediated tumor immunity.
Devon Heroux, Ada W Y Leung, Roger Gilabert-Oriol, Jayesh Kulkarni, Malathi Anantha

Int J Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial characterization of redox processes and speciation of Ru(III) anticancer complexes by F magnetic resonance imaging.
Gregory A MacNeil, Stephanie W Chang, Kathleen E Prosser, Eric Ye, Devon Heroux

Chem Commun (Camb)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Functional Accessibility, Actionability, and Quality of Patient Education Materials from Canadian Cancer Agencies.
Courtney van Ballegooie, Devon Heroux, Peter Hoang, Sarthak Garg

Curr Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferrocene-appended anthraquinone and coumarin as redox-active cytotoxins.
Aryan Houshmand, Devon Heroux, Dennis Y Liu, Wen Zhou, Roger G Linington

Dalton Trans· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation.
Ada W Y Leung, Kent T J Chen, Gemma M Ryan, Malathi Anantha, Nicole Wretham, Devon Heroux

J Control Release· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer.
Thomas Cordonnier, Jennifer L Bishop, Masaki Shiota, Ka Mun Nip, Daksh Thaper, Devon Heroux

Int J Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis